Skip to main content

Table 1 Study design schedule

From: Acupuncture for prostatectomy incontinence: study protocol for a multicenter single-blind randomized parallel controlled trial

Contents

Research period

Screening

Baseline

Treatment (W1–6)

Follow-up (W7–24)

W−1

W0

W1

W2

W4

W6

W12

W18

W24

Visit

V0

V1

V2

V3

V4

V5

V6

V7

V8

Name

×

×

       

Age

×

×

       

Contact information

×

        

Inclusion/exclusion criteria

×

        

Informed consent

×

        

Screening dispose

×

        

Randomization

×

        

Vital signs1

×

×

×

×

×

×

   

Blood routine2

×

×

   

×

   

Urine routine3

×

×

   

×

   

Biochemical items4

×

×

   

×

   

ECG5

×

×

   

×

   

Height

 

×

       

Weight

 

×

       

BMI6

 

×

       

Education and occupation

 

×

       

Karnofsky score

 

×

       

ECOG score7

 

×

       

Personal history8

 

×

       

Past histories

 

×

       

Physical examination9

 

×

×

×

×

×

   

Diagnosis time

 

×

       

Pathological type

 

×

       

Gleason score

 

×

       

Clinical stages

 

×

       

Operation type

 

×

       

Treatment of PPI

 

×

×

×

×

×

×

×

×

Treatment of PCa

 

×

×

×

×

×

×

×

×

Daily water consumption

 

×

×

×

×

×

×

×

×

Drink preference

 

×

×

×

×

×

×

×

×

Postoperative extubation time

 

×

       

Time of incontinence

 

×

       

ICIQ-UI SF10

 

×

   

×

×

×

×

1-h pad test

 

×

  

×

×

   

72-h voiding diary

 

×

×

×

×

×

×

×

×

EPIC-2611

 

×

   

×

×

×

×

SAS12

 

×

   

×

×

×

×

Weekly consumption of pads

 

×

×

×

×

×

×

×

×

Severity of PPI

 

×

   

×

×

×

×

Self-assessment

     

×

×

×

×

Blind assessment

     

×

   

Major AE of PCa13

  

×

×

×

×

×

×

×

AE14

  

×

×

×

×

×

×

×

SAE15

  

×

×

×

×

×

×

×

  1. Notes:
  2. 1Vital signs: blood pressure, pulse, body temperature, and respiration
  3. 2Blood routine: hemoglobin, red blood cell count, white blood cell count, lymphocyte, neutrophil, and platelet count
  4. 3Urine routine: white blood cell, red blood cell, protein, and ketone body
  5. 4Biochemical items: alkaline phosphatase, alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin, urea nitrogen, glomerular filtration rate, creatinine, glucose, triglyceride, total cholesterol, high-density lipoprotein, low-density lipoprotein, potassium, sodium, calcium
  6. 5ECG: electrocardiogram
  7. 6BMI: body mass index
  8. 7ECOG score: Eastern Cooperative Oncology Group score
  9. 8Personal history: including family history, smoking history, drinking history, drug and food allergy history, marriage history, occupational exposure history
  10. 9Physical examination: the researchers will conduct a comprehensive physical examination at baseline, including general appearance, skin, neck (including thyroid), eyes, ears, nose, throat, lung, heart, abdomen, back, lymph nodes, limbs, and nervous system examination. All other visits will have a brief physical examination, i.e., a general appearance examination
  11. 10ICIQ-UI SF: International Consultation Incontinence Questionnaire-Urinary Incontinence Short Form
  12. 11EPIC-26: The Expanded Prostate Cancer Index Composite 26-item version
  13. 12SAS: Self-Rating Anxiety Scale is a 20-item self-report assessment
  14. 13Major adverse event (AE) of prostate cancer (PCa): it refers to the AEs related to the progression of PCa from the time of enrollment to the end of follow-up
  15. 14AE: It refers to the AEs caused by the intervention measures of the project from the time of admission to the end of follow-up
  16. 15SAE: It refers to the serious adverse events caused by the intervention measures of the project during the period from enrollment to the end of follow-up